Antibody response to SARS-CoV-2 in people living with HIV

J Microbiol Immunol Infect. 2021 Feb;54(1):144-146. doi: 10.1016/j.jmii.2020.09.005. Epub 2020 Oct 2.

Authors

Shinya Yamamoto¹, Makoto Saito¹, Etsuko Nagai¹, Keiko Toriuchi¹, Hiroyuki Nagai¹, Hiroshi Yotsuyanagi¹, Yu Nakagama², Yasutoshi Kido², Eisuke Adachi³

Affiliations

¹ Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
² Department of Parasitology, Graduate Scholl of Medicine, Osaka City University, Osaka, Japan.
³ Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Electronic address: eadachi-ims@umin.ac.jp.

No abstract available

Keywords: COVID-19; HIV; PLWH; Seroconversion; Serology.

Publication types

Letter

MeSH terms

Adult
Antibodies, Viral / blood*
COVID-19 / epidemiology
COVID-19 / immunology*
Comorbidity
False Negative Reactions
HIV Infections / epidemiology*
Humans
Male
Middle Aged
Retrospective Studies
SARS-CoV-2 / immunology
Seroconversion
Transgender Persons

Substances

Antibodies, Viral